Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: FilerBill who wrote (585)	4/6/1997 2:37:00 PM
From: Bryan Arnold	of 6136

I went to that Project Inform website and the stuff that I saw on it is not very up to date. The last item that I saw on PI was updated on 11/96. A good five months ago. As for Viracept and diarrhea, I would much rather deal with only diarrhea then have to deal with kidney stones. Also, Viracept does not have to be taken on an empty stomach as Crixivan does. Both of the drugs have advantages but I think that Viracept's advantages outweigh Crixivan. I think that many people invested in Agouron have read up and know something about the drugs. Just my thought. Bryan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next